We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
Cap. Flow
-$301M
Cap. Flow %
-0.68%
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$209M
2
CVS icon
CVS Health
CVS
+$195M
3
TSN icon
Tyson Foods
TSN
+$136M
4
XOM icon
ExxonMobil
XOM
+$135M
5
LYB icon
LyondellBasell Industries
LYB
+$130M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$239M
2
MSFT icon
Microsoft
MSFT
+$204M
3
JNJ icon
Johnson & Johnson
JNJ
+$157M
4
AMZN icon
Amazon
AMZN
+$144M
5
WMT icon
Walmart Inc
WMT
+$137M

Sector Composition

Rank Sector Weight
1 Technology 20.23%
2 Healthcare 16.49%
3 Financials 11.74%
4 Industrials 11.47%
5 Consumer Discretionary 10.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELL
2076
DELISTED
PhenomeX Inc. Common Stock
CELL
$115K ﹤0.01%
23,224
-87,510
-79% -$458K
PLYA
2077
DELISTED
Playa Hotels & Resorts
PLYA
$113K ﹤0.01%
+16,410
New +$136K
RSI icon
2078
Rush Street Interactive
RSI
$2.86B
$112K ﹤0.01%
24,079
+5,642
+31% +$33.6K
HARP
2079
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$111K ﹤0.01%
5,815
+3,282
+130% +$85K
EYPT icon
2080
EyePoint Inc
EYPT
$1.13B
$110K ﹤0.01%
13,921
+282
+2% +$2.83K
MRSN
2081
DELISTED
Mersana Therapeutics
MRSN
$108K ﹤0.01%
936
+428
+84% +$40.3K
HT
2082
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$108K ﹤0.01%
11,016
-5,218
-32% -$52.2K
ASXC
2083
DELISTED
Asensus Surgical, Inc.
ASXC
$106K ﹤0.01%
+265,963
New +$119K
JNCE
2084
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$106K ﹤0.01%
34,981
-56,290
-62% -$274K
STXS icon
2085
Stereotaxis
STXS
$143M
$104K ﹤0.01%
56,756
-16,352
-22% -$39.1K
KPTI icon
2086
Karyopharm Therapeutics
KPTI
$44.4M
$102K ﹤0.01%
1,508
-347
-19% -$31.8K
CFFN icon
2087
Capitol Federal Financial
CFFN
$1.08B
$101K ﹤0.01%
+11,002
New +$109K
MAGN
2088
Magnera Corp
MAGN
$466M
$101K ﹤0.01%
1,130
-1,654
-59% -$198K
CVGI icon
2089
Commercial Vehicle Group
CVGI
$134M
$100K ﹤0.01%
+17,206
New +$117K
FLWS icon
2090
1-800-Flowers.com
FLWS
$255M
$100K ﹤0.01%
10,463
-26,958
-72% -$298K
EAR
2091
DELISTED
Eargo, Inc. Common Stock
EAR
$98K ﹤0.01%
+6,495
New +$307K
BCAB icon
2092
BioAtla
BCAB
$5.76M
$97K ﹤0.01%
+683
New +$109K
FTI icon
2093
TechnipFMC
FTI
$29.1B
$97K ﹤0.01%
14,345
-30,966
-68% -$236K
CHS
2094
DELISTED
Chicos FAS, Inc.
CHS
$97K ﹤0.01%
19,484
-130,890
-87% -$662K
ALLK
2095
DELISTED
Allakos
ALLK
$95K ﹤0.01%
30,266
-20,163
-40% -$75.3K
INN
2096
Summit Hotel Properties
INN
$670M
$94K ﹤0.01%
12,941
-605
-4% -$5.32K
KGC icon
2097
Kinross Gold
KGC
$32.5B
$94K ﹤0.01%
26,259
-867
-3% -$4.19K
LGF.A
2098
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$94K ﹤0.01%
10,178
-14,300
-58% -$175K
SYRS
2099
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$93K ﹤0.01%
9,665
+7,801
+419% +$73K
AUY
2100
DELISTED
Yamana Gold, Inc.
AUY
$92K ﹤0.01%
19,781
-936
-5% -$5.07K
82 83
84
85 86

Similar funds

CTC (Chicago Trading Company)
CTC (Chicago Trading Company) Chicago, Illinois $217B AUM 46.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM

AQR Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
  • AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
  • AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
  • AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
  • AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
  • AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
  • AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.

Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.